Douglas J. Mahoney
Calgary, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.
Journal: Nature cancer
Published: April 29, 2026
Development and computational analysis of high dimensional spectral flow cytometry data for the resolution of innate lymphoid cells in the mammary tumor microenvironment.
Journal: Frontiers in immunology
Published: October 22, 2025
Pathological disruption of CELF2 shuttling causes neuronal hyperactivity, learning deficits, and seizures.
Journal: The Journal of clinical investigation
Published: September 11, 2025
Genetic variants disrupting activity-dependent CELF2 shuttling cause neuronal hyperexcitability, learning deficits, and seizures.
Journal: medRxiv : the preprint server for health sciences
Published: July 16, 2025
The role of non-cancer cell infections in oncolytic virus therapy.
Journal: Seminars in immunology
Published: May 07, 2025
Renal cell carcinoma with fibromyomatous stroma (RCC FMS) and with hemangioblastoma-like areas is part of the RCC FMS spectrum in patients with tuberous sclerosis complex.
Journal: Histopathology
Published: December 30, 2024
Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cells.
Journal: Nature
Published: December 09, 2024
Divergent sex-specific pannexin-1 mechanisms in microglia and T cells underlie neuropathic pain.
Journal: Neuron
Published: May 08, 2024
Last Updated: 09/26/2026